A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers

Inclusion Criteria: * Subject is an ambulatory adult and between 18 and 55 years old (inclusive) at the screening visit * Subject is in good health and has no clinically significant findings on physical examination * Body mass index is \> 18 and \< 30 kg/m2 at the screening visit * Women of reproductive potential must have a negative pregnancy test at screening at at the time of check-in and must agree to use protocol-specified contraception throughout the duration of the study and until 90 days after receiving the final study drug dose * Men must agree to use protocol-specified contraception and also to not donate sperm throughout the study and until 90 days after receiving the final study drug dose * Other inclusion criteria per protocol Exclusion Criteria: * Any active or unstable clinically significant medical condition * Use of any prescribed or non-prescribed medication (except for hormonal birth control) * Other exclusion criteria per protocol